Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience

[1] Connolly SJ(2000)Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Avid, cash and cids studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study Eur Heart J 21 2071-2078

[2] Hallstrom AP(2004)Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials J Am Coll Cardiol 44 2166-2172

[3] Cappato R(2014)Icd therapy for primary prevention of sudden cardiac death after mustard repair for d-transposition of the great arteries Clin Res Cardiol 103 894-901

[4] Schron EB(2013)Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus Clin Res Cardiol 102 169-170

[5] Kuck KH(2015)Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy Clin Res Cardiol 104 288-303

[6] Zipes DP(2015)Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: a prospective observational study Clin Res Cardiol 104 666-671

[7] Greene HL(2014)Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging Clin Res Cardiol 103 75-77

[8] Boczor S(2014)Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the effortless s-icd registry Eur Heart J 35 1657-1665

[9] Domanski M(2015)Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the ide study and effortless registry J Am Coll Cardiol 65 1605-1615

[10] Follmann D(2014)The subcutaneous defibrillator: a review of the literature J Am Coll Cardiol 63 1473-1479

[1] Connolly SJ(2000)Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Avid, cash and cids studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study Eur Heart J 21 2071-2078

[2] Hallstrom AP(2004)Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials J Am Coll Cardiol 44 2166-2172

[3] Cappato R(2014)Icd therapy for primary prevention of sudden cardiac death after mustard repair for d-transposition of the great arteries Clin Res Cardiol 103 894-901

[4] Schron EB(2013)Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus Clin Res Cardiol 102 169-170

[5] Kuck KH(2015)Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy Clin Res Cardiol 104 288-303

[6] Zipes DP(2015)Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: a prospective observational study Clin Res Cardiol 104 666-671

[7] Greene HL(2014)Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging Clin Res Cardiol 103 75-77

[8] Boczor S(2014)Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the effortless s-icd registry Eur Heart J 35 1657-1665

[9] Domanski M(2015)Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the ide study and effortless registry J Am Coll Cardiol 65 1605-1615

[10] Follmann D(2014)The subcutaneous defibrillator: a review of the literature J Am Coll Cardiol 63 1473-1479